GL1X · GenesisL1 explorer

Research workbench

Crystal structure of mouse angiotensinogen in the reduced form

Analyse Crystal structure of mouse angiotensinogen in the reduced form in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
2WXY
Type
protein
Length
419 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Angiotensinogen
UniProt
P11859
Ligands
NA
Pockets
4 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 30% helix, 32% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
CAngiotensinogenprotein41930% helix, 32% strandP11859

Ligands and binding sites

  • NA · Sodium ion · metal · 4 copies · chains C
  • EDO · 1,2-ethanediol · additive · 5 copies · chains C

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11160.470.7926empty
2550.310.7614empty
3620.300.7514EDO, NA
4660.290.7315empty

Compared structures

  • 2WXY · Crystal structure of mouse angiotensinogen in the reduced form · the same entry in another collection · chain C against C, TM-score 1.00
  • P11859 · AlphaFold monomer V2.0 prediction for angiotensinogen (P11859) · a predicted model of the same protein · chain C against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.